LLY

961.82

-2.72%↓

JNJ

241.58

-0.43%↓

ABBV

221.77

-0.26%↓

NVS

154.71

-0.15%↓

AZN

192.41

+0.27%↑

LLY

961.82

-2.72%↓

JNJ

241.58

-0.43%↓

ABBV

221.77

-0.26%↓

NVS

154.71

-0.15%↓

AZN

192.41

+0.27%↑

LLY

961.82

-2.72%↓

JNJ

241.58

-0.43%↓

ABBV

221.77

-0.26%↓

NVS

154.71

-0.15%↓

AZN

192.41

+0.27%↑

LLY

961.82

-2.72%↓

JNJ

241.58

-0.43%↓

ABBV

221.77

-0.26%↓

NVS

154.71

-0.15%↓

AZN

192.41

+0.27%↑

LLY

961.82

-2.72%↓

JNJ

241.58

-0.43%↓

ABBV

221.77

-0.26%↓

NVS

154.71

-0.15%↓

AZN

192.41

+0.27%↑

Home・Aandelen Lijst・Pulmatrix Inc

Pulmatrix Inc

Open

2.07 1.97

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

2.02

Max

2.14

Belangrijke statistieken
By Trading Economics
Inkomsten	-51K -928K
EPS	-0.24
Winstmarge	-60,266.667
Werknemers	2
EBITDA	-51K -928K

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-3.9M 7.5M
Vorige openingsprijs	0.1
Vorige sluitingsprijs	2.07

Pulmatrix Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

16 mrt 2026, 21:37 UTC

Acquisities, Fusies, Overnames

Lensar and Alcon Agree to Terminate Merger

16 mrt 2026, 19:06 UTC

Belangrijke Nieuwsgebeurtenissen

Mideast Loses 12 Million Boe/d Following Hormuz Closure: Rystad -- OPIS

16 mrt 2026, 17:44 UTC

Acquisities, Fusies, Overnames

Novartis Issues Debt Offering to Help Fund $12 Billion Acquisition of Avidity Biosciences

16 mrt 2026, 23:46 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

16 mrt 2026, 23:46 UTC

Marktinformatie

Nikkei May Rise After Oil Prices Decline -- Market Talk

16 mrt 2026, 23:37 UTC

Marktinformatie

Gold Edges Higher on Possible Technical Recovery -- Market Talk

16 mrt 2026, 23:05 UTC

Marktinformatie

Slumping Consumer Confidence Highlights Risk Around RBA Hike -- Market Talk

16 mrt 2026, 21:56 UTC

Marktinformatie

DUG Technology's Stock Fall Creates Opportunity -- Market Talk

16 mrt 2026, 21:41 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Global Equities Roundup: Market Talk

16 mrt 2026, 21:41 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Clouds Gather Over Auckland Intl Airport as Airlines Up Fares -- Market Talk

16 mrt 2026, 20:59 UTC

Acquisities, Fusies, Overnames

Alcon: Transaction Unattractive to Pursue Further in Light of FTC's Opposition

16 mrt 2026, 20:59 UTC

Acquisities, Fusies, Overnames

Alcon: Delay and Associated Costs of Extended Regulatory Review Has Rendered Deal Unattractive to Pursue Further

16 mrt 2026, 20:59 UTC

Acquisities, Fusies, Overnames

Alcon Entered Agreement With LENSAR to Terminate Merger Agreement

16 mrt 2026, 20:57 UTC

Acquisities, Fusies, Overnames

Alcon and LENSAR, Inc. Agree to Terminate Merger Agreement

16 mrt 2026, 20:51 UTC

Acquisities, Fusies, Overnames

Nvidia-Backed Nscale Plans Huge Data Center Cluster in West Virginia -- WSJ

16 mrt 2026, 20:50 UTC

Marktinformatie

Financial Services Roundup: Market Talk

16 mrt 2026, 20:50 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Energy & Utilities Roundup: Market Talk

16 mrt 2026, 20:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

16 mrt 2026, 20:50 UTC

Marktinformatie

Health Care Roundup: Market Talk

16 mrt 2026, 19:53 UTC

Belangrijke Nieuwsgebeurtenissen

U.S. Allies Rebuff Trump's Demand for Help Opening Strait of Hormuz -- WSJ

16 mrt 2026, 19:43 UTC

Marktinformatie

Global Equities Roundup: Market Talk

16 mrt 2026, 19:43 UTC

Marktinformatie

Nvidia Sees $1 Trillion in Blackwell, Rubin Orders Through 2027 -- Market Talk

16 mrt 2026, 19:37 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Natural Gas Follows Oil Prices Lower -- Market Talk

16 mrt 2026, 19:20 UTC

Belangrijke Nieuwsgebeurtenissen

Stock Market Today: Dow Jumps, Brent Crude Pulls Back From $105 -- WSJ

16 mrt 2026, 19:17 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Crude Oil Sinks on Signals from Strait of Hormuz -- Market Talk

16 mrt 2026, 19:00 UTC

Marktinformatie

Bank of Canada Needs Dovish Approach Based on Weak Data -- Market Talk

16 mrt 2026, 18:23 UTC

Marktinformatie

LME Restarts Trading After Outage -- Market Talk

16 mrt 2026, 17:36 UTC

Belangrijke Nieuwsgebeurtenissen

Oil Prices Fall as Trump Says Hormuz Help Is Coming. Tankers Getting Through, Bessent Adds. -- Barrons.com

16 mrt 2026, 17:19 UTC

Marktinformatie

Grains Sink as Investors Steer Toward Equities -- Market Talk

16 mrt 2026, 17:14 UTC

Belangrijke Nieuwsgebeurtenissen

Trump Ends News Conference

Peer Vergelijking

Prijswijziging

Pulmatrix Inc Prognose

Beoordelingsconsensus

By TipRanks

0 ratings

Buy

Hold

Sell

Gebaseerd op 0 analisten die aandelenratings hebben gegeven aan Pulmatrix Inc - Dist in de afgelopen 3 maanden.

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Pulmatrix Inc

Pulmatrix, Inc., a clinical stage biotechnology company, focused on development of novel inhaled therapeutic products to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. It engages in developing PUR1800, a narrow spectrum kinase inhibitor completed Phase 1b clinical trials for the treatment of acute exacerbations in chronic obstructive pulmonary disease; PUR1900 for the treatment of allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis; and PUR3100, an iSPERSE formulation of dihydroergotamine which is in Phase 1 for the treatment of acute migraine. It has a license agreement with RespiVert Ltd. for access to a portfolio of kinase inhibitor drug candidates. The company was founded in 2003 and is headquartered in Bedford, Massachusetts.